Reading between the (Genetic) Lines: How Epigenetics is Unlocking Novel Therapies for Type 1 Diabetes

Type 1 diabetes (T1D) is an autoimmune condition where the body’s immune cells destroy their insulin-producing pancreatic beta cells leading to dysregulated glycaemia. Individuals with T1D control their blood glucose through exogenous insulin replacement therapy, often using multiple daily injection...

Descripción completa

Detalles Bibliográficos
Autores principales: Akil, Ammira-Sarah AL-Shabeeb, Jerman, Laila F., Yassin, Esraa, Padmajeya, Sujitha S., Al-Kurbi, Alya, Fakhro, Khalid A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692667/
https://www.ncbi.nlm.nih.gov/pubmed/33153010
http://dx.doi.org/10.3390/cells9112403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692667/
https://www.ncbi.nlm.nih.gov/pubmed/33153010
http://dx.doi.org/10.3390/cells9112403

Ejemplares similares